PHASE II STUDY OF 2,5-DIAZIRIDINYL-3,6-BIS-CARBOETHOXYAMINO-1,4-BENZOQUINONE (AZO, NSC 182986) IN RECURRENT MALIGNANT GLIOMAS

被引：0
|
作者：
FEUN, LG [1 ]
SAVARAJ, N [1 ]
BEDIKIAN, AY [1 ]
LEAVENS, M [1 ]
BURGESS, MA [1 ]
LU, K [1 ]
SMITH, RG [1 ]
BENJAMIN, RS [1 ]
BODEY, GP [1 ]
机构：
[1] UNIV TEXAS,CANC CTR INST,HOUSTON,TX 77030
来源：
PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH | 1982年 / 23卷 / MAR期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：151 / 151
页数：1
相关论文
共 27 条
  • [1] CLINICAL-PHARMACOLOGY OF 2,5-DIAZIRIDINYL-3,6-BIS-CARBOETHOXYAMINO-1,4-BENZOQUINONE, (AZQ, NSC 182986)
    LU, K
    SAVARAJ, N
    YAP, BS
    BEDIKIAN, AY
    FEUN, LG
    LOO, TL
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1981, 22 (MAR): : 180 - 180
  • [2] PHASE-II AND PHARMACOKINETIC STUDY OF AZIRIDINYLBENZOQUINONE [2,5-DIAZIRIDINYL-3,6-BIS(CARBOETHOXYAMINO)-1,4-BENZOQUINONE, DIAZIQUONE, NSC-182986] IN HIGH-GRADE GLIOMAS
    CURT, GA
    KELLEY, JA
    KUFTA, CV
    SMITH, BH
    KORNBLITH, PL
    YOUNG, RC
    COLLINS, JM
    CANCER RESEARCH, 1983, 43 (12) : 6102 - 6105
  • [3] MITOCHONDRIAL TOXICITY OF 2,5-DIAZIRIDINYL-3,6-BIS-(CARBOETHOXYAMINO)-1,4-BENZOQUINONE
    OBERCGREENWOOD, MA
    SMITH, BH
    COOKE, C
    ELLIS, JR
    KORNBLITH, PL
    MCKEEVER, PE
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1983, 71 (04) : 723 - 733
  • [4] A PHASE-II TRIAL OF 2,5-DIAZIRIDINYL3,6-BIS(CARBOETHOXYAMINO)1,4-BENZOQUINONE(AZQ,NSC-182986) IN RECURRENT PRIMARY BRAIN-TUMORS
    FEUN, LG
    YUNG, WKA
    LEAVENS, ME
    BURGESS, MA
    OBBENS, EA
    BEDIKIAN, AY
    SAVARAJ, N
    STEWART, DJ
    BENJAMIN, RS
    FIELDS, WS
    BODEY, GP
    JOURNAL OF NEURO-ONCOLOGY, 1984, 2 (01) : 13 - 17
  • [5] 2,5-DIAZIRIDINYL-3,6-BIS(CARBOETHOXYAMINO)-1,4-BENZOQUINONE .2. ISOLATION AND CHARACTERIZATION OF DEGRADATION PRODUCTS
    POOCHIKIAN, GK
    KELLEY, JA
    JOURNAL OF PHARMACEUTICAL SCIENCES, 1981, 70 (02) : 162 - 167
  • [6] TISSUE DISTRIBUTION AND INTRA-CEREBRAL TUMOR PENETRATION OF 2,5-DIAZIRIDINYL-3,6-BISCARBOETHOXYAMINO-1,4-BENZOQUINONE (AZQ,NSC 182986) IN MAN
    SAVARA, N
    LU, K
    STEWART, D
    LEAVENS, M
    BEDEKIAN, A
    FEUN, L
    LOO, TL
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1981, 22 (MAR): : 351 - 351
  • [7] CELLULAR ACTIVATION OF DIAZIQUONE [2,5-DIAZIRIDINYL-3,6-BIS (CARBOETHOXYAMINO)-1,4-BENZOQUINONE] TO ITS FREE-RADICAL SPECIES
    GUTIERREZ, PL
    EGORIN, MJ
    FOX, BM
    FRIEDMAN, R
    BACHUR, NR
    BIOCHEMICAL PHARMACOLOGY, 1985, 34 (09) : 1449 - 1455
  • [8] COMPARISON OF THE STRUCTURAL AND CYTOTOXIC ACTIVITY OF NOVEL 2,5-BIS(CARBOETHOXYAMINO)-3,6-DIAZIRIDINYL-1,4-BENZOQUINONE ANALOGS
    DZIELENDZIAK, A
    BUTLER, J
    HOEY, BM
    LEA, JS
    WARD, TH
    CANCER RESEARCH, 1990, 50 (07) : 2003 - 2008
  • [9] PHARMACOLOGY FATE OF 2,5-DIAZIRIDINYL-3,6-BISCARBOETHOXY-AMINO-1,4-BENZOQUINONE (AZQ NSC-182986) BY INTRA-CAROTID (IC) OR INTRAVENOUS (IV) ADMINISTRATION IN BEAGLES
    GUO, ZG
    LU, K
    SAVARAJ, N
    FEUN, LG
    HUANG, MT
    LOO, TL
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1982, 23 (MAR): : 218 - 218
  • [10] INDUCTION OF DNA STRAND BREAKS AND CROSS-LINKS BY 2,5-DIAZIRIDINYL-3,6-BIS(CARBOETHOXYAMINO)-1,4-BENZOQUINONE IN CHINESE-HAMSTER OVARY CELLS
    KING, CL
    HITTELMAN, WN
    LOO, TL
    CANCER RESEARCH, 1984, 44 (12) : 5634 - 5637
123